Cenra Inc.

TWSE:3716 Stock Report

Market Cap: NT$5.4b

Cenra Past Earnings Performance

Past criteria checks 4/6

Cenra's earnings have been declining at an average annual rate of -5.1%, while the Pharmaceuticals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 2.4% per year. Cenra's return on equity is 5%, and it has net margins of 4.2%.

Key information

-5.1%

Earnings growth rate

-3.7%

EPS growth rate

Pharmaceuticals Industry Growth18.5%
Revenue growth rate2.4%
Return on equity5.0%
Net Margin4.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Cenra makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TWSE:3716 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 248,9353722,460498
30 Jun 248,8713552,449485
31 Mar 248,7623282,440472
31 Dec 238,5753222,416486
30 Sep 238,6193172,513463
30 Jun 238,5993872,474470
31 Mar 238,5724892,348457
31 Dec 228,4574782,283436
30 Sep 228,1475262,076417
30 Jun 227,9815282,016400
31 Mar 227,9364772,070399
31 Dec 217,9495182,062391
30 Sep 218,1024592,222402
30 Jun 218,2114482,216429
31 Mar 218,0885742,124436
31 Dec 208,1815572,134444
30 Sep 208,0615312,040476
30 Jun 208,0065122,057448
31 Mar 208,0754122,121456
31 Dec 197,9703852,150452
30 Sep 197,6303602,143426
30 Jun 197,6693682,161438
31 Mar 197,5473432,135422
31 Dec 187,5803702,125403
30 Sep 187,5623742,042381
30 Jun 187,0833721,787364
31 Mar 186,7143261,571347
31 Dec 176,2453111,301344
30 Sep 175,9882931,160340
30 Jun 175,8482571,130330
31 Mar 175,8223051,103324
31 Dec 165,7813131,077325
30 Sep 165,7853111,050319
30 Jun 165,7713621,046323
31 Mar 165,7173521,032320
31 Dec 155,6283541,040327
30 Sep 155,5684501,043346
30 Jun 155,4713951,017348
31 Mar 155,3503841,009358
31 Dec 145,297348982362
30 Sep 145,257253974363
30 Jun 145,274260976364
31 Mar 145,271266983358
31 Dec 135,174240977355

Quality Earnings: 3716 has high quality earnings.

Growing Profit Margin: 3716's current net profit margins (4.2%) are higher than last year (3.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 3716's earnings have declined by 5.1% per year over the past 5 years.

Accelerating Growth: 3716's earnings growth over the past year (17.2%) exceeds its 5-year average (-5.1% per year).

Earnings vs Industry: 3716 earnings growth over the past year (17.2%) exceeded the Pharmaceuticals industry 11.9%.

Return on Equity

High ROE: 3716's Return on Equity (5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 10:47
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cenra Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wei Zheng KitCitigroup Inc
Ryan LiuIBTS Investment Consulting Co., Ltd.
Regina LeeJih Sun Securities Investment Consulting Co., Ltd.